Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,133 JPY | -0.77% | -1.71% | +1.95% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
ETFs positioned on Takeda Pharmaceutical Company Limited
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 20 M€ | +1.28% | - | |
0.20% | 7 M€ | +6.59% | - | |
0.16% | 29 M€ | +8.37% | - | |
0.15% | 264 M€ | -.--% | - | |
0.15% | 187 M€ | +10.81% | - | |
0.15% | 477 M€ | +12.77% | ||
0.15% | 2 M€ | +9.19% | - | |
0.15% | 2 M€ | -.--% | - | |
0.15% | 205 M€ | -.--% | ||
0.15% | 32 M€ | +9.19% | - | |
0.13% | 284 M€ | -.--% | ||
0.12% | 786 M€ | -.--% | ||
0.12% | 23 M€ | -.--% | - | |
0.12% | 206 M€ | -.--% | ||
0.08% | 1,166 M€ | +0.26% | - | |
0.08% | 607 M€ | +0.05% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.07% | 391 M€ | +9.42% | - | |
0.06% | 34 M€ | +9.50% | - | |
0.06% | 34 M€ | +4.49% | - | |
0.05% | 45 M€ | 0.00% | - | |
0.05% | 39 M€ | +6.43% | - | |
0.05% | 306 M€ | +6.36% | - | |
0.04% | 105 M€ | +3.80% | - | |
0.03% | 17 M€ | +3.36% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.95% | 41.87B | |
+34.35% | 705B | |
+31.18% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.42% | 238B | |
-3.15% | 210B | |
+10.44% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- 4502 Stock
- Funds and ETFs Takeda Pharmaceutical Company Limited